期刊
NEUROBIOLOGY OF AGING
卷 34, 期 1, 页码 338-350出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2012.05.010
关键词
Alzheimer's disease; Tau-ELISA; Tau transgenic mice; htau; JNPL3; Sera
资金
- Eli Lilly and Co.
- [NIMH38623]
- [NIH-AG022102]
Transgenic mouse models have been an invaluable resource in elucidating the complex roles of beta-amyloid and tau in Alzheimer's disease. Although many laboratories rely on qualitative or semiquantitative techniques when investigating tau pathology, we have developed 4 Low-Tau, Sandwich enzyme-linked immunosorbent assays (ELISAs) that quantitatively assess different epitopes of tau relevant to Alzheimer's disease: total tau, pSer-202, pThr-231, and pSer-396/404. In this study, after comparing our assays with commercially available ELISAs, we demonstrate our assay's high specificity and quantitative capabilities using brain homogenates from tau transgenic mice, htau, JNPL3, and tau knockout. All 4 ELISAs show excellent specificity for mouse and human tau, with no reactivity to tau knockout animals. An age-dependent increase of serum tau in both tau transgenic models was also seen. Taken together, these assays are valuable methods to quantify tau and phospho-tau levels in transgenic animals, by examining tau levels in brain and measuring tau as a potential serum biomarker. (C) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据